A panelist discusses how the COAT trial showed that switching patients with uncontrolled dry eye disease on cyclosporine 0.05% to the 0.09% solution led to significant improvements in corneal staining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback